Recurrence Patterns of Squamous Cell Carcinoma of the Penis: Recommendations for Follow-Up Based on a Two-Centre Analysis of 700 Patients

Leijte, Joost A.P.; Kirrander, Peter; Antonini, Ninja; Windahl, Torgny; Horenblas, Simon

doi:10.1016/j.eururo.2008.04.016

Cited by 315 publications

(182 citation statements)

References 17 publications

Supporting

Mentioning

162

Contrasting

Unclassified

Order By: Relevance

“…Although PSS was associated with an increased risk of local failure, it did not appear to compromise long-term cancer-specific survival. The five-year cancer-specific survival rate following local recurrence was 92% in two large studies (1,6). In addition, sexual function, micturition and cosmetic results were generally well maintained following conservative surgery (3,(6)(7)(8)(20)(21)(22)(23).…”

Section: Discussionmentioning

confidence: 90%

See 1 more Smart Citation

Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis

Zhu

Wang

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

Abstract. Current guidelines recommend penile sparing surgery (PSS) for selected penile cancer cases. The present study described the use of PSS in a population-based cohort, and also examined the role of PSS on penile cancer-specific mortality (PCSM). Data from the Surveillance, Epidemiology, and End Results (SEER) database were used to identify individuals that were diagnosed with penile squamous cell carcinoma between 1998 and 2009 and treated with surgery. Patients were sorted into two groups: Local tumor excision (LTE) and partial/total penectomy (PE). Factors associated with the receipt of LTE and PCSM following LTE were examined. In addition, PCSM was compared between LTE and PE following propensity score matching. Of the 1,292 eligible patients, 24.2% underwent LTE. For stage T1 disease, the rates of LTE increased moderately from 29 to 40% over the last decade. Following multivariate analyses, young age, African descent, a tumor size of <3 cm and stage T1 disease were identified to positively influence the receipt of LTE. With a median follow-up period of 55 months, the four-year PCSM rate was 9.8% in patients treated with LTE. Older age, a tumor size of 3-4 cm and regional/distant disease (SEER stage) were significant predictors of PCSM. Furthermore, in matched cohorts with stage T1 disease, the four-year PCSM rates were 8.9 and 10.0% for patients that received LTE or PE, respectively (P=0.93). In conclusion, underuse of PSS is pronounced in the general community with significant age and ethnicity disparities. The current population-based study provides evidence supporting the oncological safety of PSS compared with PE in early-stage disease.

show abstract

Section: Discussionmentioning

confidence: 90%

“…Partial or total penectomy (PE) has historically been considered the standard treatment for invasive disease (1). Although the local control rate of PE is ~95% (1), it has a significant negative impact on the patient's sexual function, quality of life, social interactions, self-image and self-esteem (2).…”

Section: Introductionmentioning

confidence: 99%

Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis

Zhu

Wang

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

show abstract

“…Local recurrence rates were higher with penile preservation compared to partial or total amputation (27.7% versus 5.3%) (34). Five year disease specific survival in those who locally recurred was 92%, however, prompting the authors to conclude that there is little impact on survival from utilizing phallic preservation techniques (34).…”

Section: Surgery Of the Primary Tumormentioning

confidence: 97%

“…It is likely best utilized in tumors smaller than 4 cm with less than 1 cm of invasion (29). Neodymium: yttrium-aluminum-garnet (Nd: Yag) and CO2 lasers have been used primarily in early stage penile cancers, and may be particularly effective for carcinoma in situ or for T1 and T2 lesions that are 3 cm or smaller (8,(32)(33)(34). Some no longer apply this technology to T2 tumors as there may be a higher risk for nodal metastasis (35).…”

Section: Surgery Of the Primary Tumormentioning

confidence: 99%

Update in the management of penile cancer

et al. 2009

View full text Add to dashboard Cite

Purpose: The management of penile cancer has evolved as less invasive techniques are applied in the treatment of the primary tumor and inguinal lymph nodes. Materials and Methods: Herein we review the literature focusing on advances in the preservation of the phallus as well as less morbid procedures to evaluate and treat the groins. Results: Promising imaging modalities for staging are discussed. New techniques are described and tables provided for penile preservation. We also review the contemporary morbidity of modified surgical forms for evaluation of the inguinal nodes. Conclusions: Advances in surgical technique have made phallic preservation possible in a greater number of primary penile cancers. The groins can be evaluated for metastasis with greater accuracy through new radiologic means as well as with less morbid modified surgical techniques.

show abstract

“…Leijte JA et al, in their retrospective study, analyzed 700 patients from two referral centers for penile carcinoma for recurrences and compared laser therapy, WLE, and radiotherapy to partial or total penectomy. They concluded that local disease recurrence rates were lower with the latter treatment (5.3 vs. 27.7%) but there was no significant difference in overall disease survival [43]. Also, patients undergoing penile-preserving therapy (pN+), and those undergoing a wait-and-see policy for the nodal status are at high risk of developing a recurrence [44][45][46][47][48].…”

Section: Partial Penectomymentioning

confidence: 99%

Organ Preservation Surgery for Carcinoma Penis

Yuvaraja

Waigankar

Dharmadhikari

et al. 2016

Indian J Surg Oncol

View full text Add to dashboard Cite

Carcinoma of the penis is not uncommon in India. A sizeable number of patients do not report to the doctors in fear of mutilation to the organ and hence subsequently end up with advanced disease. Many patients with T1 or T2 disease when carefully selected are amenable to organ-preserving penile procedures including surgery, topical therapy, laser, and radiation therapy. Identification of appropriate patients and institution of these treatments has been noted to produce oncologically comparable results to extirpative surgeries. In this article, we review the criteria to identify patients qualifying for organ-preserving treatments and also review outcomes with a variety of penile-preserving procedures.

show abstract

Recurrence Patterns of Squamous Cell Carcinoma of the Penis: Recommendations for Follow-Up Based on a Two-Centre Analysis of 700 Patients

Cited by 315 publications

References 17 publications

Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis

Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis

Update in the management of penile cancer

Organ Preservation Surgery for Carcinoma Penis

Contact Info

Product

Resources

About